130 related articles for article (PubMed ID: 7130967)
1. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ
J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.
Purcell RH; Gerin JL
Am J Med Sci; 1975; 270(2):395-9. PubMed ID: 828832
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.
Davis HL; McCluskie MJ; Gerin JL; Purcell RH
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7213-8. PubMed ID: 8692971
[TBL] [Abstract][Full Text] [Related]
4. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
[TBL] [Abstract][Full Text] [Related]
5. Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine.
Tabor E; Barker LF; Gerety RJ
J Med Virol; 1981; 6(4):279-84. PubMed ID: 7241095
[TBL] [Abstract][Full Text] [Related]
6. Successful postexposure vaccination against hepatitis B in chimpanzees.
Iwarson S; Wahl M; Ruttimann E; Snoy P; Seto B; Gerety RJ
J Med Virol; 1988 Aug; 25(4):433-9. PubMed ID: 3171558
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
[TBL] [Abstract][Full Text] [Related]
8. [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].
Stamm B; Gerlich W; Thomssen R
Med Microbiol Immunol; 1979 May; 167(2):83-97. PubMed ID: 572908
[TBL] [Abstract][Full Text] [Related]
9. Development and chimpanzee testing of a vaccine against human hepatitis B.
Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
Proc Soc Exp Biol Med; 1976 Apr; 151(4):694-700. PubMed ID: 817293
[TBL] [Abstract][Full Text] [Related]
10. Immunization of chimpanzees with hepatitis B virus-derived polypeptides.
Dreesman GR; Hollinger FB; Sanchez Y; Oefinger P; Melnick JL
Infect Immun; 1981 Apr; 32(1):62-7. PubMed ID: 7216495
[TBL] [Abstract][Full Text] [Related]
11. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
[TBL] [Abstract][Full Text] [Related]
12. Formaldehyde treatment of hepatitis B micelle vaccine.
Skelly J; Howard CR; Zuckerman AJ
J Virol Methods; 1981 Jul; 3(1):51-9. PubMed ID: 7263826
[No Abstract] [Full Text] [Related]
13. Lack of genetic restriction by a potential anti-idiotype vaccine for type B viral hepatitis.
Kennedy RC; Eichberg JW; Dreesman GR
Virology; 1986 Jan; 148(2):369-74. PubMed ID: 3484564
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses.
Krugman S; Holley HP; Davidson M; Simberkoff MS; Matsaniotis N
J Med Virol; 1981; 8(2):119-21. PubMed ID: 7299377
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the immunogenic activity of hepatitis B surface antigen (HBsAg) and HBsAg polypeptides.
Sanchez Y; Ionescu-Matiu I; Melnick JL; Dreesman GR
J Med Virol; 1983; 11(2):115-24. PubMed ID: 6842190
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus vectored vaccines.
Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
[TBL] [Abstract][Full Text] [Related]
18. Synthetic hepatitis B surface antigen peptide vaccine.
Dreesman GR; Sparrow JT; Frenchick PJ; Kennedy RC
Adv Exp Med Biol; 1985; 185():129-37. PubMed ID: 2416196
[TBL] [Abstract][Full Text] [Related]
19. Subunit, recombinant and synthetic hepatitis B vaccines.
Zuckerman AJ
Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates.
Lee GC; Hwang LY; Beasley RP; Chen SH; Lee TY
J Infect Dis; 1983 Sep; 148(3):526-9. PubMed ID: 6225807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
